News

404

Tomas Hode, Ph.D.

Tomas Hode, Ph.D.

CHIEF INNOVATION OFFICER, PRESIDENT & CO-FOUNDER
Dr. Hode is a co-founder of Immunophotonics and has 30 years’ experience both in academic research and in the life science industry. He started his career in Sweden in the early 90s, working with manufacturing and sales of medical devices, including tumor ablation devices. He later took a PhD at Stockholm University, Sweden, focusing on microanalytical development for applications in space and planetary science, and then moved to the USA on a post-doc to study the development and structure of microbial biofilms. Dr. Hode subsequently returned to industry and co-founded Immunophotonics Inc, and currently holds the role of President and Chief Innovation Officer, where he is overseeing all the technical aspects of the company, and driving innovation. Additionally, Dr. Hode is the chairman of a medical device company in Sweden, is a program committee member of the “Biophotonics and Immune Responses” conference of SPIE, and was previously a board member of the Missouri Biotechnology Association (MOBIO).

CHIEF INNOVATION OFFICER, PRESIDENT & CO-FOUNDER
Dr. Hode is a co-founder of Immunophotonics and has 30 years’ experience both in academic research and in the life science industry. He started his career in Sweden in the early 90s, working with manufacturing and sales of medical devices, including tumor ablation devices. He later took a PhD at Stockholm University, Sweden, focusing on microanalytical development for applications in space and planetary science, and then moved to the USA on a post-doc to study the development and structure of microbial biofilms. Dr. Hode subsequently returned to industry and co-founded Immunophotonics Inc, and currently holds the role of President and Chief Innovation Officer, where he is overseeing all the technical aspects of the company, and driving innovation. Additionally, Dr. Hode is the chairman of a medical device company in Sweden, is a program committee member of the “Biophotonics and Immune Responses” conference of SPIE, and was previously a board member of the Missouri Biotechnology Association (MOBIO).

Scroll to top